verb / verso / 《話》very / velocity / volt[s] / volume / vide
English Journal
[Vasculitis and vasculopathy].
Marković A.SourceSveti Duh University Hospital, Department of Clinical Immunology, Pulmonology and Rheumatology, Zagreb, Croatia.
Acta medica Croatica : c̆asopis Hravatske akademije medicinskih znanosti.Acta Med Croatica.2012 Oct;66 Suppl 1:19-24.
Many pathophysiological process components are known to be implicated in lower limb ulcerations, among which vascular lesions have a major role. Vasculitis denotes a heterogeneous group of clinical entities which all are characterized by the inflammatory process of arterial and venous walls of any s
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).
Schmitz S, Kaminsky-Forrett MC, Henry S, Zanetta S, Geoffrois L, Bompas E, Moxhon A, Mignion L, Guigay J, Knoops L, Hamoir M, Machiels JP.SourceCancer Center, Department of Medical Oncology, University Hospital St-Luc, Catholic University Louvain, Brussels, Belgium.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.Ann Oncol.2012 Aug;23(8):2153-61. doi: 10.1093/annonc/mdr574. Epub 2012 Jan 10.
BACKGROUND: Preclinical studies suggest that insulin-like growth factor-1 receptor (IGF-1R) blockage could be a promising therapeutic target in squamous cell carcinoma of the head and neck (SCCHN). Therefore, we investigated the efficacy and toxicity of figitumumab, an anti-IGF-1R monoclonal antibod
Brands: Carimune, Gamimune N 10%, Gamimune N 5%, Gammagard S/D, Gammar-P I.V., Iveegam, Panglobulin, Polygam S/D, Sandoglobulin, Venoglobulin-S 10%, Venoglobulin-S 5% What is the most important information I · ...